This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carlin, C R Articles by Knowles, B B Search for Related Content PubMed PubMed Citation Articles by Carlin, C R Articles by Knowles, B B

 Previous Article  |  Next Article 

Mol Cell Biol. 1988 January; 8(1): 25-34

Expression and biosynthetic variation of the epidermal growth factor receptor in human hepatocellular carcinoma-derived cell lines.

Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania 19104.

ABSTRACT

Expression of the epidermal growth factor (EGF) was analyzed in six human hepatocellular carcinoma-derived and one human hepatoblastoma-derived cell line, each of which retained the differentiated phenotype and functions of the parenchymal hepatocyte. The level of receptor expression of each hepatoma cell line was similar to that of the normal human fibroblast, approximately 10(5) molecules per cell. However, NPLC/PRF/5, a subline of the PLC/PRF/5 cell line obtained following reestablishment of a xenograft tumor in vitro, was found to express 4 x 10(6) high-affinity EGF receptor molecules per cell. Proliferation of the NPLC/PRF/5 cell line was inhibited in the presence of nanomolar quantities of ligand. Receptor overexpression was found to result from EGF receptor gene amplification without apparent rearrangement of the EGF receptor coding sequences. Although cell-specific variability in posttranslational processing of EGF receptor N-linked oligosaccharides in the hepatoma cell lines was found, no difference between the receptors in PLC/PRF/5 and NPLC/PRF/5 was observed and no aberrant receptor-related species were detected. EGF receptor gene amplification in the NPLC/PRF/5 cell line is probably a reflection of genome instability and selection of variants with augmented growth potential in limiting concentrations of EGF in vivo. When viewed in this light, EGF receptor overexpression could represent a manifestation of tumor progression in the EGF-responsive hepatocyte.

This article has been cited by other articles:

• Cianciola, N. L., Crooks, D., Shah, A. H., Carlin, C. (2007). A Tyrosine-Based Signal Plays a Critical Role in the Targeting and Function of Adenovirus RID{alpha} Protein. J. Virol. 81: 10437-10450 [Abstract] [Full Text]  
• Zhu, A. X. (2006). Systemic Therapy of Advanced Hepatocellular Carcinoma: How Hopeful Should We Be?. The Oncologist 11: 790-800 [Abstract] [Full Text]  
• Keese, M., Magdeburg, R. J., Herzog, T., Hasenberg, T., Offterdinger, M., Pepperkok, R., Sturm, J. W., Bastiaens, P. I. H. (2005). Imaging Epidermal Growth Factor Receptor Phosphorylation in Human Colorectal Cancer Cells and Human Tissues. J. Biol. Chem. 280: 27826-27831 [Abstract] [Full Text]  
• Wölfl, S., Martinez, C., Majzoub, J. A. (1999). Inducible Binding of Cyclic Adenosine 3',5'-Monophosphate (cAMP)-Responsive Element Binding Protein (CREB) to a cAMP-Responsive Promoter in Vivo. Mol. Endocrinol. 13: 659-669 [Abstract] [Full Text]